Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelomonocytic, Chronic × enzalutamide × Clear all

Sponsor

Conditions

Prostatic Neoplasms 59 Breast Neoplasms 9 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Neoplasms 4 Prostate Cancer Metastatic 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Metastatic Castration-resistant Prostate Cancer 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Metastatic Hormone Sensitive Prostate Cancer 2 Metastatic Castration Resistant Prostate Cancer 2 Melanoma 2 mCRPC 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Small Cell Lung Carcinoma 1 Seizures 1 Salivary Cancer 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Pancreatic Neoplasms 1 Neoplasms, Squamous Cell 1 Metastatic Progressive Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castrate-Resistant Prostate Cancer 1 Mesothelioma 1 Lymphoma, Mantle-Cell 1

Interventions

fludarabine phosphate 32 Cyclophosphamide 27 Whole-Body Irradiation 25 Mycophenolic Acid 24 Azacitidine 24 Tacrolimus 20 Peripheral Blood Stem Cell Transplantation 20 Busulfan 20 Cyclosporine 14 Methotrexate 12 Antilymphocyte Serum 12 Decitabine 11 Cytarabine 11 Melphalan 10 Filgrastim 8 fludarabine 7 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 thymoglobulin 6 Sirolimus 6 Rituximab 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 Clofarabine 6 venetoclax 5 Cyclosporins 5 Sorafenib 4 Injections 4 Flow Cytometry 4 pevonedistat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡